(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATION (Tables)

12 Months Ended

Dec. 31, 2020

Disclosure of loss on discontinued operation [Abstract]

Schedule of Loss on Remeasurement of Assets and Liabilities

The operating loss for the Cardiac point-of-care tests operation in Sweden and the (loss)/profit on re-measurement of its assets and liabilities are summarised as follows: 

	December 31, 2020 US$‘000			December 31, 2019 US$‘000			December 31, 2018 US$‘000
(Loss)/Profit on re-measurement of assets and liabilities:
Closure provision		127			(8	)		(22	)
Foreign currency translation reserve		(64	)		85			—
Tax (expense)/credit		(438	)		—			590
Total (loss)/profit		(375	)		77			568
(Loss)/Profit for the year from discontinued operations		(375	)		77			568

Schedule of Earnings Per ADS for Discontinued Operations

	December 31, 2020			December 31, 2019		December 31, 2018
Basic (loss)/earnings per ADS (US Dollars) – discontinued operations		(0.02	)		0.00		0.03
Diluted (loss)/earnings per ADS (US Dollars) – discontinued operations		(0.02	)		0.00		0.02
Basic (loss)/earnings/ per ‘A’ share (US Dollars) – discontinued operations		0.00			0.00		0.01
Diluted (loss)/earnings per ‘A’ share (US Dollars) – discontinued operations		0.00			0.00		0.01

Schedule of Cash Flows Attributable to Discontinued Operations

The cash flows attributable to discontinued operations are as follows:

	December 31, 2020			December 31, 2019			December 31, 2018
	US$000			US$000			US$000
Cash flows from operating activities		(22	)		(5	)		527